DXN is trading at A$0.29, up +5.45%, with no clear company-specific catalyst identified for October 19.

  • The latest listed close was A$0.28 on October 16.
  • Recent coverage refers to earlier contracts, not a new catalyst. Risk-off U.S. futures point in the opposite direction, and the reason for DXNā€™s rise remains unclear.